VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

President Joko Widodo reviewed the COVID-19 vaccine immunization simulation at the Tanah Sereal Public Health Center Harapan Keluarga, Bogor, West Java.

"This morning I came to the Puskesmas in Tanah Sereal in Bogor City because yesterday I heard that there will be simulations for vaccinations," said President Jokowi at the Tanah Sereal Community Health Center, Bogor, Wednesday.

President Jokowi arrived at the Puskesmas at 08.21 WIB. At the location also accompanied the President, namely Minister of Health Terawan Agus Putranto and Mayor of Bogor Bima Arya.

The President then observes the community who participated in the simulation.

The participants came from various backgrounds such as traders, housewives, city government employees to online motorcycle taxi drivers.

Participants sit on seats at a distance and wait for the queue number. Then the participants came to several tables to check their identity and health condition, whether they have congenital diseases (comorbid) or not.

Participants whose identities and health conditions have been checked then enter the Puskesmas to be given the COVID-19 vaccine.

"And because I live here, I stopped by this Tanah Sereal Community Health Center," added the President.

The government is known to have signed an agreement to procure 143 million doses of vaccine concentrate with Chinese pharmaceutical companies Sinovac, Sinopharm, and CanSino, respectively 65 million and 15 million to 20 million vaccine concentrates.

The vaccine is planned to be produced by state-owned company PT Bio Farma.

Apart from China, Indonesia has collaborated on vaccines with the G-24 technology company from the United Arab Emirates (UAE) in mid-August by supplying 10 million doses of vaccine in collaboration with PT Kimia Farma.

Then there are 100 million doses of the COVID-19 vaccine produced by AstraZeneca, it is hoped that the first delivery can be made in the second quarter of 2021.

At the same time, the Eijkman Institute for Molecular Biology (LBM) is also developing the Red and White vaccine as a domestically made COVID-19 vaccine which is different from the COVID-19 vaccine from Sinovac. (Antaranews)